Limin Guo Selected Research

Limin Guo Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 11/2008
3	Hepatocellular Carcinoma (Hepatoma) 12/2015 - 01/2013
2	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2021 - 01/2020
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 09/2014
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 12/2016
2	Sudden Death 04/2019 - 04/2016
2	Hemorrhage 10/2016 - 09/2014
1	Hypertension (High Blood Pressure) 10/2021
1	Ganglion Cysts (Ganglion) 10/2021
1	Neuroinflammatory Diseases 10/2021
1	Tertiary Lymphoid Structures 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Osteoporosis 01/2021
1	Poisoning 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Stroke (Strokes) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Diabetic Foot 10/2018
1	Colorectal Neoplasms (Colorectal Cancer) 10/2018
1	Infections 10/2018
1	Synovial Sarcoma (Synovioma) 11/2017
1	Neuroblastoma 10/2017
1	Amyloid Plaque 10/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2016
1	Epistaxis (Nosebleed) 10/2016
1	Allergic Rhinitis 02/2015
1	Nasal Obstruction 02/2015
1	Carcinogenesis 09/2014
1	Spinal Injuries (Spinal Injury) 09/2014
1	Angiofibroma 08/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2013
1	Respiratory Insufficiency (Respiratory Failure) 09/2012
1	Critical Illness (Critically Ill) 09/2012
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2012
1	Human Influenza (Influenza) 09/2012
1	Fibrosis (Cirrhosis) 10/2010

Drug/Important Bio-Agent (IBA)

2	InflammasomesIBA 10/2021 - 01/2020
2	ElectrolytesIBA 04/2019 - 04/2016
2	BerberineIBA 01/2019 - 10/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 10/2017
2	Pharmaceutical PreparationsIBA 10/2018 - 10/2010
2	Peptides (Polypeptides)IBA 10/2017 - 01/2013
2	Oxygen (Dioxygen)IBA 04/2016 - 09/2012
2	Cell-Free Nucleic AcidsIBA 12/2015 - 11/2015
1	MelatoninIBA 10/2021
1	Retinaldehyde (Retinal)IBA 10/2021
1	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 10/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	TensinsIBA 01/2020
1	SolventsIBA 04/2019
1	SolutionsIBA 04/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2017
1	Hematoxylin (Haematoxylon)IBA 11/2017
1	AntigensIBA 11/2017
1	AMP-Activated Protein KinasesIBA 10/2017
1	Amyloidogenic ProteinsIBA 12/2016
1	ginsenoside ReIBA 12/2016
1	Biomarkers (Surrogate Marker)IBA 11/2015
1	azelastine (Optivar)FDA LinkGeneric 02/2015
1	Histamine Antagonists (Antihistamines)IBA 02/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2015
1	Nasal SpraysIBA 02/2015
1	Fluticasone (Cutivate)FDA LinkGeneric 02/2015
1	Adenosine Monophosphate (AMP)IBA 09/2014
1	adenylate cyclase 3IBA 09/2014
1	Interleukin-17 (Interleukin 17)IBA 09/2014
1	CytokinesIBA 09/2014
1	meglumine cyclic adenylateIBA 09/2014
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 09/2014
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2014
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2013
1	EpitopesIBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2010
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2010
1	salvianolic acid BIBA 10/2010
1	rhodamine BIBA 10/2010
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2008
1	Small Interfering RNA (siRNA)IBA 11/2008

Therapy/Procedure

2	Therapeutics 01/2020 - 02/2015
1	Immunotherapy 01/2021
1	Drug Therapy (Chemotherapy) 10/2018
1	Electrocoagulation (Electrocautery) 10/2016
1	Electrodes (Electrode) 04/2016
1	Extracorporeal Membrane Oxygenation 09/2012
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 09/2012